Loading
A phase 1 trial of Ilixadencel run by Mendus, completed.
A Study to Evaluate the Safety of Intuvax Administered Intra-tumorally in Patients With Gastrointestinal Stromal Tumors is a phase 1 interventional study registered as NCT02686944 by Mendus, with 6 participants enrolled, started 2016-06-01. Conditions recorded: Gastrointestinal Stromal Tumor. Interventions recorded: Intuvax (ilixadencel).
Shares Ilixadencel, Mendus and the tag pipeline.
Shares Ilixadencel, Mendus and the tag pipeline.
Shares Ilixadencel, Mendus and the tag pipeline.
Shares Mendus and the tag pipeline.
Shares Mendus and the tag pipeline.
Shares Mendus and the tag pipeline.
Shares Mendus and the tag pipeline.
Shares Gastrointestinal stromal tumour (GIST) and the tag pipeline.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/